ArticleBreast cancer (Tokyo, Japan)2026

Changes in CD8-positive lymphocytes following chemotherapy with concomitant bevacizumab in HER2-negative breast cancer.

Eriko Narusawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.